[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(11/05, THU) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)

 이노비오, '플라스미드 DNA' 면역치료제 "첫 FDA 승인" 
[https://www.biospectator.com/news/view/30296](https://www.biospectator.com/news/view/30296)

 HLB 베리스모, 'MSLN CAR-T' 전임상 "SITC 초록공개"
[https://www.biospectator.com/news/view/30294](https://www.biospectator.com/news/view/30294)

 화이자, 인수 멧세라 'GIPR+GLP-1' 비만1상 "개발중단"
[https://www.biospectator.com/news/view/30293](https://www.biospectator.com/news/view/30293)

 루닛, 랩콥·셀카르타와 'AI' 공동연구 결과 "SITC 공개" 
[https://www.biospectator.com/news/view/30304](https://www.biospectator.com/news/view/30304)

 큐로셀, CAR-T '림카토' 3년 장기추적 결과 "ASH 발표"
[https://www.biospectator.com/news/view/30309](https://www.biospectator.com/news/view/30309)

 아이젠, 의료특화 AI모델 '미어캣2' 논문 "EMNLP 발표"
[https://www.biospectator.com/news/view/30300](https://www.biospectator.com/news/view/30300)

 中인벤티스, '경구 TYK2 저해제' 건선 3상 "경쟁력"
[https://www.biospectator.com/news/view/30277](https://www.biospectator.com/news/view/30277)

 GC셀, 'CD5 CAR-NK' 림프종 1상 "전체데이터 발표" 
[https://www.biospectator.com/news/view/30313](https://www.biospectator.com/news/view/30313)

 리가켐, 'CD19 ADC' 1상 "ORR 53%"..DAR1 ADC도 공개 
[https://www.biospectator.com/news/view/30308](https://www.biospectator.com/news/view/30308)

 SK바팜, 내년 2~3건 "추가 임상진입"..어떤 후보물질? 
[https://www.biospectator.com/news/view/30317](https://www.biospectator.com/news/view/30317)

 SK바팜, 3Q 매출 2584억·영업익 1163억 "최대실적" 
[https://www.biospectator.com/news/view/30316](https://www.biospectator.com/news/view/30316)

 HLB 베리스모, 'CD19 CAR-T' 혈액암 1상 "ORR 80%"
[https://www.biospectator.com/news/view/30314](https://www.biospectator.com/news/view/30314)

 자이메디, 'TLR2/6 작용제' 기반 다중기전 암백신 "논문"
[https://www.biospectator.com/news/view/30258](https://www.biospectator.com/news/view/30258)

 베링거, 中시노 ‘전임상 ADC·TCE 6종’ 73.5억弗 옵션
[https://www.biospectator.com/news/view/30310](https://www.biospectator.com/news/view/30310)

 사노피 "갑작스럽게", 누릭스 'STAT6 분해제' 개발중단
[https://www.biospectator.com/news/view/30303](https://www.biospectator.com/news/view/30303)

 파밍, 영진약품 '미토콘드리아 신약' 日판권까지 사들여 
[https://www.biospectator.com/news/view/30319](https://www.biospectator.com/news/view/30319)

[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(11/05, THU) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)